je.st
news
Dyax shares advance on positive study results
2015-04-04 12:15:49| Biotech - Topix.net
Shares of Dyax Corp. moved higher again on Thursday, a day after they gained 55 percent on news the biotechnology company's potential inflammatory condition treatment met key goals in a study and will get a faster FDA review. Shares of Dyax closed Thursday at $27.05, up $1.30.
Tags: results
study
positive
advance
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||